August 12, 2025

Ocular Therapeutix Announces FDA Approves NPDR Trial Plan for OTX-TKI

A Special Protocol Assessment (SPA) establishes a regulatory path for Ocular Therapeutix’s Axpaxli in diabetic eye disease.

Ophthalmology Management

August 11, 2025

First MacTel Patient Receives Encelto Treatment

The procedure marks the initial commercial use since FDA approval of the cell therapy earlier this year.

Retinal Physician

August 11, 2025

4DMT Presents Positive 60-Week Results from 4D-150 SPECTRA Clinical Trial in DME

The positive results from the SPECTRA trial demonstrate the tolerability and consistent, durable clinical activity of 4D-150 in DME.

Ophthalmology Management

August 05, 2025

Large US Study Adds to Connection Between NAION Risks and GLP-1 Drugs

Semaglutide and liraglutide showed the highest risk, while dulaglutide and exenatide were not significantly associated with NAION.

Ophthalmology Management

August 05, 2025

What Do Patients Look for in Health Care Facilities?

An analysis of online reviews of health care facilities identified language patterns associated with positive or negative patient experiences.

Conexiant

July 30, 2025

August is Children’s Eye Health and Safety Month

Prevent Blindness provides new resources

Optometric Management

July 23, 2025

Vision Care Organizations Launch Campaign to Defend NEI Amid Federal Funding Threats

A coalition of leading eyecare and research organizations has launched a nationwide campaign to protect the National Eye Institute (NEI) from proposed federal restructuring and funding cuts.

Optometric Management

June 01, 2025

Preservation of Vision in GA in ARCHER Trial Continues Evaluation in ARCHER II

Discover the potential breakthrough in preserving vision in geographic atrophy presented by Dr. Priya Vakharia at the Retina World Congress.

Retinal Physician

July 14, 2025

Video: Fellow Eye Data Supports GA Clinical Trial Design

At ASRS, Diana Do, MD, presented results of a post hoc analysis of the OAKS and DERBY trials of geographic atrophy growth rates in untreated eyes vs sham eyes.

Retinal Physician